通过Cocrystal工程黄素加速伤口愈合,减少痕
Ali Samie1,2, Hoda Alavian1,2, Zeinab Vafaei-Pour3,4
1Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 9177948954, Iran.
Molecular pharmaceutics
|August 25, 2023
概括
这项研究表明,与单独使用黄素相比,黄素-黄素共晶 (CUR-PYR) 显著改善伤口愈合并减少痕. 在体内,CUR-PYR表现出优异的抗菌和细胞活力效应,导致伤口更快地关闭和痕形成最小.
科学领域:
- 制药科学和超分子化学.
- 伤口愈合和再生医学.
- 药物输送和材料科学.
背景情况:
- 制药共晶是人工设计的固体,可以增强药物的物理化学性质.
- 黄素 (CUR) 具有治疗潜力,但其溶解性和生物可用性不佳.
- 这项研究探讨了用于伤口愈合和痕减少的制药共晶.
研究的目的:
- 为了合成和表征一种库尔库明 - 铁醇共晶体 (CUR-PYR).
- 评估CUR-PYR在促进伤口愈合和减少痕方面的有效性.
- 为了研究CUR-PYR的体外和体内性能.
主要方法:
- 通过液体辅助研磨 (LAG) 合成的CUR-PYR,并使用FT-IR,DSC和PXRD进行了表征.
- 在体外抗菌检测对抗格拉姆阴性和格拉姆阳性细菌.
- 在人体皮肤纤维细胞 (HDF) 和NIH-3T3细胞的体外细胞活力研究.
- 在老鼠体内15天内进行伤口愈合研究,将CUR-PYR膏与对照剂进行比较.
主要成果:
- 与CUR相比,CUR-PYR表现出增强的抗菌活性和改善的HDF/NIH-3T3细胞活力.
- 用CUR-PYR膏治疗的伤口在第12天完全关闭,明显比对照组更快.
- 与其他组相比,CUR-PYR治疗导致痕最小 (3.89%).
- 组织病理学分析证实CUR-PYR的优异伤口愈合,再生和原沉积.
结论:
- 提高CUR-PYR的溶解度是加速伤口关闭和组织再生的关键.
- 制药性共晶,特别是CUR-PYR,为有效的伤口愈合和痕管理提供了一个有前途的治疗策略.
- 这项研究开创了制药共晶在伤口护理中的应用.
相关概念视频
Phases of Wound Repair
6.1K
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
6.1K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


